Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative


Hitesh

Daewoong Pharmaceutical and HanAll Biopharma invest in the broad potential of Turn Biotechnologies Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases Daewoong Pharmaceutical and HanAll Biopharma today announced expansion of their open collaboration strategy by investing in Turn Biotechnologies, a […]

Shionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticals


Hitesh

Cloudera, the hybrid data cloud company, today announced that Japanese pharmaceutical company, Shionogi & Co., Ltd., has selected Cloudera to boost its data analytics capabilities for increased business performance and realize its vision of achieving data-driven innovation. Through this partnership, Shionogi hopes to democratize access to its vast amounts of […]

Castle Biosciences to Acquire AltheaDx


Hitesh

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced it has signed a definitive agreement to acquire AltheaDx, Inc. AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that are focused on mental health. […]

THREAD and Amazon Web Services Modernize Clinical Research with Launch of Cloud-based, AI-driven Decentralized Clinical Trials Technology


Hitesh

THREAD®, the leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced today that it is collaborating with Amazon Web Services, Inc. (AWS) to launch enhancements to the THREAD platform powered by enterprise-scale automation and built-in AI-driven technologies. Read More